These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16918591

  • 1. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione.
    Kautzky-Willer A, Tura A, Winzer C, Wagner OF, Ludvik B, Hanusch-Enserer U, Prager R, Pacini G.
    Diabetes Obes Metab; 2006 Sep; 8(5):561-7. PubMed ID: 16918591
    [Abstract] [Full Text] [Related]

  • 2. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [Abstract] [Full Text] [Related]

  • 3. Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects.
    Yatagai T, Nakamura T, Nagasaka S, Kusaka I, Ishikawa SE, Yoshitaka A, Ishibashi S.
    Diabetes Res Clin Pract; 2004 Jan; 63(1):19-26. PubMed ID: 14693409
    [Abstract] [Full Text] [Related]

  • 4. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
    Willi SM, Kennedy A, Brant BP, Wallace P, Rogers NL, Garvey WT.
    Diabetes Res Clin Pract; 2002 Nov; 58(2):87-96. PubMed ID: 12213349
    [Abstract] [Full Text] [Related]

  • 5. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP, Yu JG, Kruszynska YT, Olefsky JM.
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [Abstract] [Full Text] [Related]

  • 6. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.
    Ann Intern Med; 1998 Feb 01; 128(3):176-85. PubMed ID: 9454525
    [Abstract] [Full Text] [Related]

  • 7. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
    Miyazaki Y, Matsuda M, DeFronzo RA.
    Diabetes Care; 2002 Mar 01; 25(3):517-23. PubMed ID: 11874940
    [Abstract] [Full Text] [Related]

  • 8. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K, Peters R, Kjos SL, Goico J, Marroquin A, Dunn ME, Xiang A, Azen S, Buchanan TA.
    Diabetes; 1996 Nov 01; 45(11):1572-9. PubMed ID: 8866563
    [Abstract] [Full Text] [Related]

  • 9. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
    Osei K, Gaillard T, Schuster D.
    Metabolism; 2007 Jan 01; 56(1):24-9. PubMed ID: 17161222
    [Abstract] [Full Text] [Related]

  • 10. The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.
    Schuster D, Gaillard T, Rhinesmith S, Habash D, Osei K.
    Metabolism; 2003 Sep 01; 52(9):1211-7. PubMed ID: 14506629
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec 01; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 12. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.
    Hermann LS, Ranstam J, Vaaler S, Melander A.
    Diabetes Obes Metab; 1999 Jul 01; 1(4):227-32. PubMed ID: 11228758
    [Abstract] [Full Text] [Related]

  • 13. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.
    Diabetes; 2000 Apr 01; 49(4):633-9. PubMed ID: 10871202
    [Abstract] [Full Text] [Related]

  • 14. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
    Antonucci T, Whitcomb R, McLain R, Lockwood D, Norris RM.
    Diabetes Care; 1997 Feb 01; 20(2):188-93. PubMed ID: 9118772
    [Abstract] [Full Text] [Related]

  • 15. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
    Iannello S, Camuto M, Cavaleri A, Milazzo P, Pisano MG, Bellomia D, Belfiore F.
    Diabetes Obes Metab; 2004 Jan 01; 6(1):8-15. PubMed ID: 14686957
    [Abstract] [Full Text] [Related]

  • 16. Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.
    Levin K, Hother-Nielsen O, Henriksen JE, Beck-Nielsen H.
    Diabetes Care; 2004 Jan 01; 27(1):148-54. PubMed ID: 14693981
    [Abstract] [Full Text] [Related]

  • 17. An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.
    Wallace TM, Levy JC, Matthews DR.
    Diabet Med; 2004 Jun 01; 21(6):568-76. PubMed ID: 15154941
    [Abstract] [Full Text] [Related]

  • 18. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF.
    Metabolism; 2010 Jun 01; 59(6):887-95. PubMed ID: 20015525
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI.
    N Engl J Med; 1998 Mar 26; 338(13):867-72. PubMed ID: 9516221
    [Abstract] [Full Text] [Related]

  • 20. Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.
    Prigeon RL, Kahn SE, Porte D.
    J Clin Endocrinol Metab; 1998 Mar 26; 83(3):819-23. PubMed ID: 9506734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.